Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Overweight, obesity prevalent in psychiatric inpatients

Most inpatients with psychiatric disorders are overweight or obese, say Australian researchers who urge closer monitoring of the physical health of patients with mental illnesses.

12 Jul 2012

Many bipolar patients unaware of co-occurring medical conditions

Co-occurring medical conditions are common among patients with bipolar disorder, but many may not be aware that they have such conditions, say researchers.

12 Jul 2012

Family physicians’ continuity of care pivotal in depressed terminally ill patients

The long-standing relationship between a family physician and his/her terminally ill patient is pivotal in the management of depression during palliative care, show Dutch study results.

12 Jul 2012

In-patient suicides continue to fall across all countries: Report

Deaths by suicide among mental health patients treated at home have reached 150 to 200 a year in England, latest national figures reveal - but suicides among patients on mental health wards continue to fall.

12 Jul 2012

Researchers identify set of laboratory-based biomarkers that aid in diagnosis of schizophrenia

In the current online issue of PLoS ONE, researchers at the University of California, San Diego School of Medicine say they have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize and treat the complex and confounding mental disorder.

12 Jul 2012

Many abusers switch to heroin due to new formulation of OxyContin

A change in the formula of the frequently abused prescription painkiller OxyContin has many abusers switching to a drug that is potentially more dangerous, according to researchers at Washington University School of Medicine in St. Louis.

12 Jul 2012

New book outlines cutting-edge approach to systematically address AD

ADEC Inc. - Worried about your memory? Many patients with Alzheimer's disease (AD) and individuals concerned about developing memory loss feel they have limited options. While there is no 'magic pill' to cure or prevent AD, a new book outlines a cutting-edge approach to systematically address this disease.

12 Jul 2012

Novel molecular mechanism responsible for most important symptom of major depression

Stanford University School of Medicine scientists have laid bare a novel molecular mechanism responsible for the most important symptom of major depression: anhedonia, the loss of the ability to experience pleasure.

12 Jul 2012

Daily temperature linked to bipolar admissions

Results from a Taiwanese study suggest that high daily temperatures are associated with increased hospitalization rates for mood symptoms among patients with bipolar disorder, particularly women.

11 Jul 2012

Health risks associated with H1N1 vaccine investigated

Results from two studies published in JAMA show that the H1N1 vaccination is associated with a small, but significant, increase in risk for Guillain-Barré syndrome in adults, but does not increase the risk for birth defects or problems when given to pregnant women.

11 Jul 2012

Substance use linked to poor memory, reasoning in BD

The presence of comorbid substance use disorder is associated with significantly poorer visual memory and conceptual reasoning skills in patients with bipolar disorder, US study results show.

11 Jul 2012

Factors linked with MDD transition to BD identified

A wide range of demographic, clinical, and environmental factors are associated with an increased risk for transition from major depressive disorder to bipolar disorder, US study results show.

10 Jul 2012

Broken heart syndrome arms against epinephrine high

Takotsubo cardiomyopathy, or “broken heart syndrome,” may actually protect the heart from very high levels of epinephrine, suggest results from an animal study.

10 Jul 2012

Biomarkers predict benefit of targeted therapy in metastatic renal-cell cancer

In metastatic renal-cell cancer, the level of cytokines and angiogenic factors identify those patients with an aggressive disease course who derive the greatest benefit from treatment with the molecular-targeted therapy pazopanib, a retrospective analysis of clinical trials shows.

10 Jul 2012